Kosdaq-listed EONE Diagnomics Genome Center Co. (EDGC) said on Wednesday that its Daejon-based affiliated COVID-19 detection kit developer SolGent has been registered with the U.S Federal Emergency Management Agency (FEMA) as a supplier to the federal government’s strategic stockpile.

EDGC Shares gained 5.39 percent to finish at 17,600 won ($14.42) on Wednesday.

The registration grants the Korean company a license to provide its COVID-19 sampling kits as a national strategic stockpile. The initial shipments of the company’s products are set at a volume for 150,000 persons.

SolGent hopes to seek a permanent supplier status from the federation government and build a local manufacturing site in the U.S. within two to three years.

SolGent’s COVID-19 detection kit uses real-time polymerase chain reaction (RT-PCR) to sensitively and specifically detect the virus in patient samples by amplifying a specific region in a DNA strand.

The detection kit also was approved in Korea under the emergency use authorization.

By Pulse

[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]